Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: International Journal of Molecular Sciences 23.12 (2022): 6830.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2022
- Urheber
-
Setz, Christian
Große, Maximilian
Auth, Janina
Fröba, Maria
Rauch, Pia
Bausch, Alexander
Wright, Matthew
Schubert, Ulrich
- DOI
-
10.3390/ijms23126830
- URN
-
urn:nbn:de:bvb:29-opus4-206223
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Setz, Christian
- Große, Maximilian
- Auth, Janina
- Fröba, Maria
- Rauch, Pia
- Bausch, Alexander
- Wright, Matthew
- Schubert, Ulrich
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2022
Ähnliche Objekte (12)
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta
Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta
Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination
Body temperature-controlled antiviral response and SARS-CoV-2 replication
Antiviral molecules for the intervention of SARS-CoV-2 infections
Lack of antiviral activity of darunavir against SARS-CoV-2
Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants
Peptide variants of a SARS-CoV-2 neutralizing protein
Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNAVaccinated People Against Wild- Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern
Towards cell-permeable hepatitis B virus core protein variants as potential antiviral agents
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta
Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta
Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination
Body temperature-controlled antiviral response and SARS-CoV-2 replication
Antiviral molecules for the intervention of SARS-CoV-2 infections
Lack of antiviral activity of darunavir against SARS-CoV-2
Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants
Peptide variants of a SARS-CoV-2 neutralizing protein
Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNAVaccinated People Against Wild- Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern
Towards cell-permeable hepatitis B virus core protein variants as potential antiviral agents
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta
Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta
Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination
Body temperature-controlled antiviral response and SARS-CoV-2 replication
Antiviral molecules for the intervention of SARS-CoV-2 infections
Lack of antiviral activity of darunavir against SARS-CoV-2
Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants
Peptide variants of a SARS-CoV-2 neutralizing protein
Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNAVaccinated People Against Wild- Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern